BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 141116)

  • 21. Pretransplant monitoring of donor-recipient compatibility.
    Thomas F; Thomas J; Mendez G; Kirchoff C; Lee HM
    Transplantation; 1977 Dec; 24(6):442-8. PubMed ID: 145674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 23. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture.
    Jeffery JR; Guttmann RD; Charpentier B
    Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral factors. Immunologic enhancement.
    Batchelor JR; Welsh KI; Burgos H
    Transplant Proc; 1977 Mar; 9(1):931-6. PubMed ID: 141143
    [No Abstract]   [Full Text] [Related]  

  • 26. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal transplant donor selection by mixed lymphocyte culture.
    Uehling ET; Malek GH; Kisken WA; Newton M; Weinstein AB; Bach FH
    J Urol; 1974 Feb; 111(2):137-40. PubMed ID: 4272637
    [No Abstract]   [Full Text] [Related]  

  • 29. The significance of mixed lymphocyte culture in related renal transplantation.
    Cerilli J; Newhouse YG; Fesperman DP; Brasile L
    Surgery; 1980 Nov; 88(5):631-5. PubMed ID: 6449088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histocompatibility tests in a transplantation program].
    de-Leo-Cervantes C
    Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival.
    Langhoff E; Ladefoged J; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thaysen JH
    Lancet; 1986 Jun; 1(8493):1296-7. PubMed ID: 2872430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic T cells recognizing minor transplantation antigens, and possibly a variant of the HLA-B8 molecule. Cause of rejection of an HLA-identical sibling kidney transplant?
    Pfeffer PF; Qvigstad E; Ahonen J; Thorsby E
    Transplantation; 1984 Nov; 38(5):517-22. PubMed ID: 6238461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of allograft function to the development of donor specific cellular nonreactivity in human cadaveric allograft recipients.
    Rashid A; Sengar DP; Couture RA; Harris JE
    Trans Am Soc Artif Intern Organs; 1976; 22():229-33. PubMed ID: 133496
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evidence of a specific defect in effector cell formation following kidney and liver allotransplants in humans].
    Wonigkeit K; Pichlmayr R
    Chir Forum Exp Klin Forsch; 1977 Apr; ():269-73. PubMed ID: 156112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of tissue typing, mixed lymphocyte culture, and related donor renal allograft survival.
    Cerilli J; Williams MA; Newhouse YG; Fesperman DP
    Transplantation; 1978 Oct; 26(4):218-20. PubMed ID: 151949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group.
    Oliver RT; Sachs JA; Festenstein H; Pegrum GD; Moorhead JF
    Lancet; 1972 Dec; 2(7792):1381-5. PubMed ID: 4118684
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of histocompatibility testing versus immunoreactive predisposition on kidney transplant survival.
    Kyriakides GK; Severyn W; Fuller L; Esquenazi V; Flaa C; Olson L; Miller J
    Surgery; 1982 Aug; 92(2):354-61. PubMed ID: 6213054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro generation of human mixed lymphocyte culture suppressor cells. I. Cellular characterization and specificity.
    Fuller L; Kyriakides G; Flaa C; Esquenazi V; Miller J
    Transplantation; 1980; 29(1):54-60. PubMed ID: 6445100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of graft survival may alter transplant choice.
    Check W
    JAMA; 1978 Jul; 240(2):91-4. PubMed ID: 149206
    [No Abstract]   [Full Text] [Related]  

  • 40. The biologic significance of the mixed lymphocyte kidney culture in humans.
    Roth D; Fuller L; Esquenazi V; Kyriakides GK; Pardo V; Miller J
    Transplantation; 1985 Oct; 40(4):376-83. PubMed ID: 2996186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.